A serotonergic biobehavioral signature differentiates cocaine use disorder participants administered mirtazapine

A serotonergic biobehavioral signature differentiates cocaine use disorder participants administered mirtazapine

Abstract Cocaine use disorder (CUD) patients display heterogenous symptoms and unforeseeable responses to available treatment approaches, highlighting the need to identify objective, accessible biobehavioral signatures to predict clinical trial success in this population. In the present experiments,...

Full description

Bibliographic Details
Main Authors: Liangsuo Ma, Kathryn A. Cunningham, Noelle C. Anastasio, James M. Bjork, Brian A. Taylor, Albert J. Arias, Brien P. Riley, Andrew D. Snyder, F. Gerard Moeller
Format: Article
Language:English
Published: Nature Publishing Group 2022-05-01
Series:Translational Psychiatry
Online Access:https://doi.org/10.1038/s41398-022-01934-w

Internet

https://doi.org/10.1038/s41398-022-01934-w

Similar Items